BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3505737)

  • 1. The opioid system in the restless legs and nocturnal myoclonus syndromes.
    Sandyk R; Gillman MA
    Sleep; 1986 Jun; 9(2):370-1. PubMed ID: 3505737
    [No Abstract]   [Full Text] [Related]  

  • 2. Restless legs syndrome and nocturnal myoclonus.
    Coccagna G; Lugaresi E
    Int J Neurol; 1981; 15(1-2):77-87. PubMed ID: 6927395
    [No Abstract]   [Full Text] [Related]  

  • 3. Nocturnal myoclonus and restless legs syndrome.
    Lugaresi E; Cirignotta F; Coccagna G; Montagna P
    Adv Neurol; 1986; 43():295-307. PubMed ID: 3946114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to opioids in three patients with restless legs syndrome.
    Trzepacz PT; Violette EJ; Sateia MJ
    Am J Psychiatry; 1984 Aug; 141(8):993-5. PubMed ID: 6087688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep-related non-epileptic motor phenomena.
    Provini F; Vetrugno R
    Neurol Sci; 2005 Dec; 26 Suppl 3():s176-80. PubMed ID: 16331392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonus in familial restless legs syndrome.
    Boghen D; Peyronnard JM
    Arch Neurol; 1976 May; 33(5):368-70. PubMed ID: 1267623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Restless legs and sleep apnea syndrome--random coincidence or causal relation?].
    Schönbrunn E; Riemann D; Hohagen F; Berger M
    Nervenarzt; 1990 May; 61(5):306-11. PubMed ID: 2359469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propriospinal myoclonus: a motor phenomenon found in restless legs syndrome different from periodic limb movements during sleep.
    Vetrugno R; Provini F; Plazzi G; Cortelli P; Montagna P
    Mov Disord; 2005 Oct; 20(10):1323-9. PubMed ID: 16007657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment.
    Zucconi M; Coccagna G; Petronelli R; Gerardi R; Mondini S; Cirignotta F
    Funct Neurol; 1989; 4(3):263-71. PubMed ID: 2507405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.
    Staedt J; Wassmuth F; Ziemann U; Hajak G; Rüther E; Stoppe G
    J Neural Transm (Vienna); 1997; 104(4-5):461-8. PubMed ID: 9295178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide. Short communication.
    Staedt J; Hünerjäger H; Rüther E; Stoppe G
    J Neural Transm (Vienna); 1998; 105(2-3):265-8. PubMed ID: 9660104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation and neuropharmacology of restless legs syndrome.
    Walters AS; Hening W
    Clin Neuropharmacol; 1987 Jun; 10(3):225-37. PubMed ID: 2842049
    [No Abstract]   [Full Text] [Related]  

  • 13. Dominantly inherited restless legs with myoclonus and periodic movements of sleep: a syndrome related to the endogenous opiates?
    Walters A; Hening W; Côté L; Fahn S
    Adv Neurol; 1986; 43():309-19. PubMed ID: 3946115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sleep-related movement disorders].
    Kinge E; Ulfberg J
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1888-91. PubMed ID: 19844285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some periodic phenomena arising during drowsiness and sleep in man.
    Lugaresi E; Coccagna G; Mantovani M; Lebrun R
    Electroencephalogr Clin Neurophysiol; 1972 Jun; 32(6):701-5. PubMed ID: 4121520
    [No Abstract]   [Full Text] [Related]  

  • 16. Sleep-to-wake transition movement disorders.
    Vetrugno R; Montagna P
    Sleep Med; 2011 Dec; 12 Suppl 2():S11-6. PubMed ID: 22136891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Restless legs syndrome and periodic limb movements in sleep: pathophysiology and treatment].
    Wichniak A; Wierzbicka A; Jernajczyk W
    Neurol Neurochir Pol; 2003; 37(3):633-43. PubMed ID: 14593758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain, opioids, and sleep: implications for restless legs syndrome treatment.
    Trenkwalder C; Zieglgänsberger W; Ahmedzai SH; Högl B
    Sleep Med; 2017 Mar; 31():78-85. PubMed ID: 27964861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy.
    Salvi F; Montagna P; Plasmati R; Rubboli G; Cirignotta F; Veilleux M; Lugaresi E; Tassinari CA
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):522-5. PubMed ID: 2166139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations.
    Högl B; Stefani A
    Mov Disord; 2017 May; 32(5):669-681. PubMed ID: 28186669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.